Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group

Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group

Data on the effectiveness and safety of approved SARS-CoV-2 vaccines in cancer patients are limited. This observational, prospective cohort study investigated the humoral immune response to SARS-CoV-2 vaccination in 232 cancer patients from 12 HeCOG-affiliated oncology departments compared to 100 he...

Full description

Bibliographic Details
Main Authors: Helena Linardou, Nikolaos Spanakis, Georgia-Angeliki Koliou, Athina Christopoulou, Sofia Karageorgopoulou, Nephely Alevra, Anastasios Vagionas, Nikolaos Tsoukalas, Stavroula Sgourou, Elena Fountzilas, Joseph Sgouros, Evangelia Razis, Dimitra Chatzokou, Sofia Lampaki, Eleni Res, Zacharenia Saridaki, Giannis Mountzios, George Saroglou, George Fountzilas
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
SARS-CoV-2 vaccine
cancer patient
antibody response
neutralizing IgG
anti-spike
Online Access:https://www.mdpi.com/2072-6694/13/18/4621

Internet

https://www.mdpi.com/2072-6694/13/18/4621

Similar Items